News
Aromatase inhibitors, either alone or in combination with growth hormone, can boost final height in mid-pubertal boys with ...
[13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration. A 2009 ASCO Breast Cancer Symposium review of five studies evaluated the majority of ...
Nikki Odum was on vacation with her family when she noticed something unusual — a strange shape under her armpit near her left breast. At 36 years old, this discovery was both unexpected and alarming.
Early initiation of moderate-intensity aerobic exercise during aromatase inhibitor use reduced pain and prevented pain increases among postmenopausal women with breast cancer. Early initiation of ...
Although she is now on an aromatase inhibitor, she told Today.com that she is also dealing with a lot of "grief" from feeling like she has lost her "youth and vibrance and vitality." One of the ...
AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for ...
Hormone receptor (HR)-positive HER2-negative advanced breast cancer is incurable and the aim of treatment is to delay it getting worse and extend how long people live. If the cancer has alterations in ...
Optimal lead follicle size of 19 to 23 mm was associated with improved clinical pregnancy rates among patients undergoing IUI.
C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment ...
AstraZeneca has reported positive outcomes from a planned interim analysis of the double-blind Phase III SERENA-6 trial of camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor as first ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results